Anlon Healthcare IPO allotment date is expected to be on September 1, 2025, with a scheduled listing on both BSE and NSE, on September 3. The investors can check the allotment status online by going through the websites of BSE, NSE, or Kfin Technologies.
Located in Mumbai, Maharashtra, Anlon Healthcare Limited is a chemical company that deals with the production of pharmaceutical intermediates and fine chemicals. The company offers the healthcare and chemical industries several high-quality solutions through the segments of drug development and specialty chemicals, besides other related services.
Nevertheless, the company has had a successful flotation in the primary market, which attracted notable investor interest although the secondary market environment is quite challenging. The fresh issuance of equity shares in the public issue grants Anlon Healthcare the avenue for raising funds for expansion, meeting working capital needs, and consolidating the company’s financial position.
IPO Subscription and Fundraising
The Anlon Healthcare IPO was a subscription open from August 26 to August 29, 2025, with the price bracket of ₹86–₹91 per share. The book-building issue had effectively raised ₹121.03 crores by offering 13.3 million equity shares.
The IPO left no stone unturned and gained a subscription of 7.13 times in aggregate, which is indicative of the serious demand for this kind of issue cutting across the investor categories:
- Retail Individual Investors (RIIs): Subscribed 47.30 times
- Non-Institutional Investors (NIIs): Subscribed 10.61 times
- Qualified Institutional Buyers (QIBs): Subscribed 1.07 times
The positive sign is the robust subscription that resonates with Anlon Healthcare’s expansion plans and its focus on specialty chemicals and healthcare manufacturing sectors.
Anlon Healthcare IPO Allotment Date
The company has decided the tentative IPO allotment date to be September 1, 2025. After the allotment is finalized, the shares will be credited to the demat accounts of lucky investors on September 2, 2025. However, on the same day, refunds will be issued to the unsuccessful applicants.
Anlon Healthcare’s IPO listing date, on the other hand, is expected to be on September 3, 2025, with the shares debuting on both the BSE and the NSE.
Grey Market Premium (GMP)
As of now, Anlon Healthcare shares are being traded at a low grey market premium (GMP) of ₹2 per share over the issue price of ₹91, which indicates an expected listing price of about ₹93, or a 2.2% premium. Although GMP trends are one of the tools that investors rely on to forecast listing prices, the actual market performance will depend on the forces of supply and demand on the listing day.
Also Read: Everything You Need to Know About Anlon Healthcare’s Upcoming IPO
How to Check Anlon Healthcare IPO Allotment Status
By using the BSE, NSE, and the Kfin Technologies registrar online platforms, investors are in a position to check their allotment status of the Anlon Healthcare IPO.
On BSE Website
- Go to the BSE IPO Allotment Page
- Select “Equity” as the Issue Type
- Choose “Anlon Healthcare Limited” from the drop-down
- Type in your Application Number or PAN
- After entering the details, verify the captcha and click on the Search button
On NSE Website
- Navigate to the NSE IPO Status Page
- Tick “Equity and SME IPO bids”
- Pick “Anlon Healthcare Limited”
- Write PAN and Application Number
- Click Submit to show status
On Kfin Technologies Website
- Go to the Kfin IPO Status Portal
- Select “Anlon Healthcare Limited” from the dropdown
- Fill in Application Number, Demat Account, or PAN
- Enter Captcha and click Submit
The details of the allotment will be provided instantly on the respective portal.
Expected Listing Impact
The investing community will be closely monitoring the IPO listing on September 3, 2025. The debut of Anlon Healthcare is likely to be very attractive to the healthcare and chemical stock sectors given the high subscription, especially from retail investors.
The company’s stable financial performance, along with its involvement in the rapidly growing pharmaceutical intermediates market, makes it a good candidate for sustained growth. However, short-term listing profits might be limited, due to the low GMP.
Also Read: Anlon Healthcare IPO Day 1
Key Takeaways for Investors
- IPO Allotment Date: September 1, 2025
- Demat Credit & Refunds: September 2, 2025
- IPO Listing Date: September 3, 2025 (BSE & NSE)
- Amount Raised: ₹121.03 crore
- Subscription: 7.13 times overall
- Price Band: ₹86–₹91 per share
- GMP Today: ₹2 premium per share
Anlon Healthcare IPO Allotment Update
The Anlon Healthcare IPO allotment is the result that the investors look forward to after the issue subscription. As the credit of shares is expected in the near future, it is a good idea for the applicants to look at their allotment status without any delay on BSE, NSE, or Kfin Technologies.
The market reaction to the imminent IPO listing on September 3 will be the main focus, although the signal of investor enthusiasm is the vigorous retail subscription. While awaiting the Anlon Healthcare IPO allotment, the market players are eagerly awaiting for the instant listing profits and long-run investment possibilities.
FAQ’s
Q1. What is the Anlon Healthcare IPO allotment date?
The expected date of allotment is September 1, 2025.
Q2. What are the ways that investors can use to find the Anlon Healthcare IPO allotment status?
The status can be accessed online through BSE, NSE, or Kfin Technologies.
Q3. When is the Anlon Healthcare IPO listing date anticipated?
The listing is planned for September 3, 2025, on BSE and NSE.
READ MORE ON